Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Prim… (NCT02562651) | Clinical Trial Compass
UnknownPhase 2/3
Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
Russia45 participantsStarted 2014-02
Plain-language summary
The purpose of the study is to investigate the changes of myocardial biomechanics and efficacy of doxycycline in patients with primary anterior STEMI.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age ≥ 18 and ≤ 75 years at time of randomization (18 years and older)
* ST-elevation Q wave myocardial infarction
* term admission to an intensive care unit (ICU) in the first 24 hours of onset
* the reperfusion of the infarct-related coronary artery is not later than 24 hours after the initial onset of acute transmural myocardial infarction
* written the informed consent to participate in research
Exclusion Criteria:
* atrial fibrillation, a permanent form
* valvular heart disease
* severe comorbidity
* acute heart failure according to the Killip classification IV FC (functional class)
* history of chronic heart failure (NYHA III-IV)
* poor image quality for Echocardiography
* sinus bradycardia - heart rate of under 50 beats per minute, interventricular conduction delay (QRS \> 0,11 s.) and atrioventricular block II-III degree